首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1737153

2026 年至 2032 年膽道支架市場（按產品、最終用戶、應用和地區分類）

Biliary Stents Market by Product (Biliary Metal Stents, Biliary Plastic Stents), End-User (Hospitals, Ambulatory Surgical Centers), Application (Biliopancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), & Region for 2026-2032

出版日期: 2025年05月09日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026-2032年膽道支架市場評估

膽道疾病（例如膽道狹窄和膽結石）的發生率上升顯著增加了對微創治療的需求。人們對這些治療的日益偏好推動了醫療機構對膽道支架的採用，從而擴大了市場規模。根據 Verified Market Research 分析師預測，膽道支架市場規模將在 2024 年下降至 3.4219 億美元，並在預測期內達到 4.9036 億美元。

膽道支架市場的快速擴張主要得益於支架技術的不斷進步，從而改善了患者的治療效果並減少了併發症。材料和設計的持續技術創新被認為是影響市場複合年成長率的關鍵因素，這將推動市場在2026年至2032年期間以4.60%的複合年成長率成長。

膽道支架市場定義/概述

膽道支架是用於治療膽管阻塞的醫療設備，膽管阻塞通常由腫瘤、膽結石、膽管狹窄和其他疾病引起。這些支架被置入膽管，以確保膽汁從肝臟正常流向腸道，從而降低感染和其他併發症的風險。膽道支架的製造材料多種多樣，包括塑膠和金屬，每種類型的選擇都基於患者的獨特需求和阻塞的嚴重程度。膽道支架通常以微創手術置入，有助於縮短患者的恢復時間並減輕不適。

膽管炎和膽道閉鎖等膽道疾病的發生率不斷上升，是推動此類支架在醫療保健領域日益普及的驅動力。此外，藥物釋放型支架和生物分解性支架等支架技術的進步，預計也將成為推動膽道支架需求成長的主要因素。這些趨勢預計將推動市場成長，提高全球患者治療的可及性和有效性。

技術進步是否影響膽道支架市場的成長？

技術進步被認為是膽道支架市場成長的主要促進因素。支架設計和材料的創新，例如全覆膜自膨式金屬支架 (FCSEMS) 和生物可吸收支架的開發，正在不斷整合，以改善患者治療效果並最大限度地減少併發症。

這些進步被認為提高了手術成功率，減少了再次手術的需求，從而鼓勵醫療保健提供者更多地採用這些技術。此外，隨著醫療保健專業人員尋求更有效率、更有效的膽道阻塞解決方案，微創技術的引入有助於擴大這些設備在全球範圍內的普及率。

影響膽道支架市場成長的主要限制因素有哪些？

膽道支架市場的成長受到支架置入手術高昂成本和專業醫護人員短缺的限制。由於成本過高，一些地區，尤其是在新興市場，難以獲得先進的膽道支架留置技術。

此外，支架移位、感染和其他併發症的風險也被認為是限制膽道支架廣泛應用的因素。此外，由於需要熟練的專家來執行該手術，這些市場限制進一步加劇，從而影響了市場成長，尤其是在醫療基礎設施有限的地區。

Allium Medical Solutions
Boston Scientific Corporation
Conmed Corporation
Cook Medical LLC
Dispomedica GmbH
ELLA-CS
sro
ENDO-FLEX GmbH
Gadelius Medical KK
I Tech Co., Ltd.
Medi-Globe GmbH
Medi-Globe Technologies GmbH
Medtronic plc
Merit Medical Systems, Inc.
Micro-Tech（Nanjing）Co., Ltd.
Olympus Corporation
Optimed Medizinische Instrumente GmbH
Bard（acquired by BD）
Taewoong Medical Co., Ltd.
Xlumena, Inc.（acquired by Boston Scientific）

第11章重大進展

產品發布/開發
合併與收購
業務擴展
夥伴關係與合作

第12章附錄

相關調查

簡介目錄

Product Code: 54505

Biliary Stents Market Valuation - 2026-2032

Rising incidences of biliary diseases, such as biliary strictures and gallstones, have significantly increased the demand for minimally invasive procedures. The growing preference for these treatments has driven the adoption of biliary stents across healthcare facilities, expanding the market size. According to the analyst from Verified Market Research, the Biliary Stents Market is estimated to reach a valuation of USD 490.36 Million over the forecast subjugating around USD 342.19 Million valued in 2024.

The rapid expansion of the biliary stents market is primarily driven by increasing advancements in stent technologies, leading to improved patient outcomes and reduced complications. The ongoing innovation in materials and design has been recognized as a key factor influencing the market's CAGR. It enables the market to grow at a CAGR of 4.60% from 2026 to 2032.

Biliary Stents Market: Definition/ Overview

Biliary stents are medical devices used to treat obstructions in the bile ducts, commonly caused by conditions such as tumors, gallstones, or strictures. These stents are inserted into the bile ducts to ensure proper bile flow from the liver to the intestine, reducing the risk of infection and other complications. Various materials, including plastic and metal, are employed in the production of biliary stents, with each type selected based on patient-specific needs and the severity of the obstruction. Minimally invasive procedures are typically used for the placement of biliary stents, contributing to faster recovery times and reduced patient discomfort.

The growing prevalence of biliary disorders, such as cholangitis and biliary atresia, has driven the increasing adoption of these stents across healthcare settings. Additionally, advancements in stent technology, including drug-eluting stents and biodegradable options, have been viewed as key factors contributing to the rising demand for biliary stents. These trends are expected to fuel market growth and enhance the accessibility and effectiveness of treatments for patients worldwide.

we are Technological Advancements Influencing the Growth of the iliary Stents Market?

Technological advancements have been recognized as a key driver in the growth of the biliary stents market. Innovations in stent design and materials, such as the development of fully covered self-expanding metal stents (FCSEMS) and bioabsorbable stents, are being integrated to enhance patient outcomes and minimize complications.

These advancements have been credited with increasing procedural success rates and reducing the need for repeat interventions, which has encouraged greater adoption by healthcare providers. Additionally, the implementation of minimally invasive techniques has been promoted as a contributing factor in expanding the global reach of these devices, as healthcare professionals seek more efficient and effective solutions for biliary obstructions.

What are the Major Restraints Affecting the Growth of the Biliary Stents Market?

The growth of the biliary stents market has been constrained by the high costs associated with stent placement procedures and the limited availability of specialized medical professionals. Access to advanced biliary stenting technology has been restricted in several regions due to the prohibitive costs, particularly in developing markets.

Furthermore, risks of stent migration, infection, and other complications have been noted as factors that may limit the widespread adoption of biliary stents. These restraints are further compounded by the requirement for skilled specialists to perform the procedures, a factor that has impacted the market growth, particularly in areas with limited healthcare infrastructure.

Category-Wise Acumens

What Factors Contribute to the Dominance of Hospitals as the Leading End-User Segment in the Biliary Stents Market?

According to VMR Analyst, the dominance of hospitals in the biliary stents market has been driven by several factors, including the availability of advanced medical infrastructure and the presence of skilled healthcare professionals. Hospitals are equipped with state-of-the-art imaging and surgical tools that allow for precise stent placement, particularly in complex cases such as biliopancreatic leakages and pancreatic cancer.

Moreover, the capacity to manage post-operative care and monitor patients for potential complications, such as stent migration or infections, has positioned hospitals as the preferred setting for biliary stent procedures. The higher patient inflow for major surgical interventions has also been seen as a factor consolidating the leadership of hospitals in this market segment.

What are the Potential Factors Driving the Growth of Biliary Metal Stents over Plastic Stents in the Market?

According to VMR Analyst, the growing preference for biliary metal stents over plastic stents has been attributed to their longer patency rates and reduced need for frequent replacements. Metal stents, particularly self-expanding metal stents (SEMS), have been found to be more durable and resistant to occlusion, making them more suitable for chronic conditions like pancreatic cancer and benign biliary strictures.

Additionally, the capability of metal stents to maintain lumen patency for extended periods has been highlighted as a key advantage in reducing hospital readmissions and intervention costs. Although plastic stents remain a cost-effective solution for temporary conditions, metal stents are being increasingly adopted due to their enhanced performance and longevity in managing long-term biliary obstructions.

Country/Region-wise Acumens

What are the Key Factors Contributing to North America's Dominance in the Biliary Stents Market?

According to VMR Analyst, North America's dominance in the biliary stents market has been primarily attributed to the region's advanced healthcare infrastructure and the high prevalence of biliary diseases, such as pancreatic cancer and gallstones. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 10-15% of adults in the United States have gallstones, representing about 25 million people.

Increased adoption of innovative stenting technologies, coupled with significant healthcare expenditure, has further strengthened the region's market position. The presence of leading medical device manufacturers and well-established reimbursement policies has facilitated access to cutting-edge biliary stent solutions. Additionally, the rising geriatric population, which is more susceptible to biliary conditions, has been recognized as a significant factor driving market growth in North America.

How is the Rapidly Growing Healthcare Sector in the Asia Pacific Influencing the Biliary Stents Market?

According to VMR Analyst, the rapidly expanding healthcare sector in the Asia Pacific has significantly influenced the growth of the biliary stents market in the region. Increasing investments in healthcare infrastructure, along with the rising prevalence of biliary disorders, have been noted as key factors driving market demand.

The Asia Pacific region is experiencing a rapid demographic shift toward an aging population, which is associated with a higher risk of biliary diseases. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the number of people aged 65 and above in the region is projected to increase from 612 million in 2022 to approximately 1.3 billion by 2050.

Countries such as China, India, and Japan have seen growing adoption of minimally invasive procedures, supported by favorable government initiatives and improved access to healthcare. Additionally, the rising awareness about advanced biliary treatments and the increasing affordability of stent procedures have contributed to the robust growth of the biliary stents market in the Asia Pacific.

Competitive Landscape

The Biliary Stents Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the biliary stents market include:

Allium Medical Solutions Ltd.

Boston Scientific Corporation

Conmed Corporation

Cook Medical LLC

Dispomedica GmbH

ELLA-CS, s.r.o.

ENDO-FLEX GmbH

ETERMED

Gadelius Medical K.K.

I. Tech Co., Ltd.

Medi-Globe GmbH

Medi-Globe Technologies GmbH

Medtronic plc

Merit Medical Systems, Inc.

Micro-Tech (Nanjing) Co., Ltd.

Olympus Corporation

Optimed Medizinische Instrumente GmbH

Bard (acquired by BD)

Taewoong Medical Co., Ltd.

Xlumena, Inc. (acquired by Boston Scientific)

Latest Developments

In February 2023, Olympus Corporation announced the acquisition of Taewoong Medical, a South Korean manufacturer of gastrointestinal (including biliary tract) metallic stents. Taewoong will receive $370 million in cash under the agreement, with $255.5 million paid at closing and the remaining $114.5 million paid based on future milestones. In May 2021, amg International GmbH, a wholly owned subsidiary of Dublin, Ireland-based Q3 Medical Devices Limited (Q3), strengthens its position as a leader in the rapid development of novel biodegradable implants. The Company announced that its second fully biodegradable product, the UNITY-B balloon expandable biodegradable biliary stent (BEBS) for endoscopic use, has received CE Mark approval. The UNITY-B will be used in conjunction with the ARCHIMEDESTM, the world's first CE-approved pancreaticobiliary biodegradable implant.

1 INTRODUCTION OF GLOBAL BILIARY STENTS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BILIARY STENTS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL BILIARY STENTS MARKET, BY PRODUCT

5.1 Overview
5.2 Biliary Metal Stents
5.3 Biliary Plastic Stent

6 GLOBAL BILIARY STENTS MARKET, BY END-USER

6.1 Overview
6.2 Hospitals
6.3 Ambulatory Surgical Centers

7 GLOBAL BILIARY STENTS MARKET, BY APPLICATION

7.1 Overview
7.2 Bilio-pancreatic Leakages
7.3 Pancreatic Cancer
7.4 Benign Biliary Strictures
7.5 Gallstones

8 GLOBAL BILIARY STENTS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL BILIARY STENTS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Allium Medical Solutions
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Boston Scientific Corporation
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Conmed Corporation
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Cook Medical LLC
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Dispomedica GmbH
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 ELLA-CS
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 s.r.o
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 ENDO-FLEX GmbH
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Gadelius Medical K.K.
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 I Tech Co., Ltd.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.11 Medi-Globe GmbH
- 10.11.1 Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Outlook
- 10.11.4 Key Developments
10.12 Medi-Globe Technologies GmbH
- 10.12.1 Overview
- 10.12.2 Financial Performance
- 10.12.3 Product Outlook
- 10.12.4 Key Developments
10.13 Medtronic plc
- 10.13.1 Overview
- 10.13.2 Financial Performance
- 10.13.3 Product Outlook
- 10.13.4 Key Developments
10.14 Merit Medical Systems, Inc.
- 10.14.1 Overview
- 10.14.2 Financial Performance
- 10.14.3 Product Outlook
- 10.14.4 Key Developments
10.15 Micro-Tech (Nanjing) Co., Ltd.
- 10.15.1 Overview
- 10.15.2 Financial Performance
- 10.15.3 Product Outlook
- 10.15.4 Key Developments
10.16 Olympus Corporation
- 10.16.1 Overview
- 10.16.2 Financial Performance
- 10.16.3 Product Outlook
- 10.16.4 Key Developments
10.17 Optimed Medizinische Instrumente GmbH
- 10.17.1 Overview
- 10.17.2 Financial Performance
- 10.17.3 Product Outlook
- 10.17.4 Key Developments
10.18 Bard (acquired by BD)
- 10.18.1 Overview
- 10.18.2 Financial Performance
- 10.18.3 Product Outlook
- 10.18.4 Key Developments
10.19 Taewoong Medical Co., Ltd.
- 10.19.1 Overview
- 10.19.2 Financial Performance
- 10.19.3 Product Outlook
- 10.19.4 Key Developments
10.20 Xlumena, Inc. (acquired by Boston Scientific)
- 10.20.1 Overview
- 10.20.2 Financial Performance
- 10.20.3 Product Outlook
- 10.20.4 Key Developments